Takeaway
People with coronavirus disease 2019 (COVID-19) who are over 60 years old and have neurologic comorbidities are at higher risk of developing critical neurologic impairment.
Why this matters
Identifying new-onset neurologic events during the acute phase of COVID-19 may help clinicians optimize treatment and management as well as improve prognosis.
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.